BioRestorative Therapies ... (BRTX)
1.81
0.00 (0.00%)
At close: Jan 15, 2025, 3:59 PM
1.80
-0.55%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Revenue | 145.80K | 119.80K | 46.00K | 77.00K | 130.00K | 111.00K | 81.00K | 36.35K | 628.91K | 416.00K | 1.68K | 15.59K | n/a | n/a |
| Cost of Revenue | n/a | 280.67K | 205.21K | n/a | n/a | n/a | 259.26K | 102.00 | 261.50K | 213.83K | 208.00 | 1.31K | n/a | n/a |
| Gross Profit | 145.80K | -160.87K | -159.21K | 77.00K | 130.00K | 111.00K | -178.26K | 36.25K | 367.41K | 202.16K | 1.47K | 14.28K | n/a | n/a |
| Operating Income | -15.22M | -18.97M | -26.31M | -2.75M | -8.43M | -7.65M | -8.37M | -7.80M | -7.17M | -4.92M | -4.75M | -5.57M | -3.55M | -2.07M |
| Interest Income | 552.29K | 11.65K | 1.82M | 1.64M | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -10.42M | -18.49M | -44.30M | -11.27M | -14.65M | -12.52M | -9.44M | -8.64M | -7.92M | -5.59M | -5.75M | -6.54M | -4.07M | -2.24M |
| Net Income | -10.42M | -18.02M | -29.94M | -12.25M | -17.92M | -12.52M | -9.44M | -8.64M | -7.92M | -5.59M | -5.75M | -6.54M | -4.07M | -2.26M |
| Selling & General & Admin | 11.33M | 15.58M | 25.62M | 1.95M | 6.84M | 6.25M | 6.30M | 4.95M | 5.43M | 3.69M | 3.16M | 5.17M | 3.54M | 2.06M |
| Research & Development | 4.03M | 3.51M | 729.06K | 876.83K | 1.72M | 1.51M | 2.15M | 2.88M | 2.11M | 1.43M | 1.59M | 416.18K | 12.00K | 11.62K |
| Other Expenses | n/a | -110.52K | -16.18M | -658.15K | -1.87M | -1.42M | -59.94K | -46.60K | 1.13M | 1.10M | 779.25K | 3.81M | 2.06M | n/a |
| Operating Expenses | 15.37M | 18.98M | 26.35M | 2.83M | 8.56M | 7.76M | 8.46M | 7.83M | 7.54M | 5.12M | 4.75M | 5.59M | 3.55M | 2.07M |
| Interest Expense | n/a | 11.65K | 1.82M | 1.64M | 5.14M | 3.22M | 1.09M | 763.94K | 263.58K | 285.27K | 371.28K | 591.81K | 260.01K | 24.16K |
| Selling & Marketing Expenses | 168.03K | n/a | 12.29K | 28.28K | 321.28K | 352.20K | 65.45K | 86.45K | 168.35K | 125.63K | 114.95K | 131.98K | 103.70K | 124.85K |
| Cost & Expenses | 15.37M | 18.98M | 26.35M | 2.83M | 8.56M | 7.76M | 8.46M | 7.83M | 7.80M | 5.34M | 4.75M | 5.59M | 3.55M | 2.07M |
| Income Tax | n/a | -479.26K | -14.36M | 981.99K | 3.27M | -1.65M | 1.03M | 717.34K | 263.58K | 285.27K | 371.28K | 591.81K | 521.93K | 194.46K |
| Shares Outstanding (Basic) | 4.22M | 3.62M | 1.19M | 394.70K | 5.57K | 2.93K | 1.53K | 1.17K | 827.00 | 424.00 | 238.00 | 186.00 | 151.00 | 1.07K |
| Shares Outstanding (Diluted) | 4.22M | 3.62M | 1.19M | 394.70K | 5.57K | 2.93K | 1.53K | 1.17K | 827.00 | 424.00 | 238.00 | 186.00 | 151.00 | 1.07K |
| EPS (Basic) | -2.47 | -4.98 | -25.21 | -31.05 | -3.22K | -4.27K | -6.18K | -7.36K | -9.58K | -13.18K | -24.16K | -35.14K | -26.98K | -2.12K |
| EPS (Diluted) | -2.47 | -4.98 | -25.21 | -31.05 | -3.22K | -4.27K | -6.18K | -7.36K | -9.58K | -13.18K | -24.16K | -35.14K | -26.98K | -2.12K |
| EBITDA | -15.06M | -18.85M | -26.22M | -9.48M | -9.29M | -9.06M | -8.10M | -7.61M | -7.11M | -4.83M | -4.65M | -5.85M | -3.38M | -1.85M |
| Depreciation & Amortization | 165.74K | 120.54K | 205.21K | 151.96K | 217.45K | 240.37K | 259.26K | 258.43K | 213.78K | 96.69K | 104.81K | 90.40K | 90.41K | 48.36K |